FDA Inspection
Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd. – FDA Inspection, Jun 17, 2025
Record Details
This FDA Inspection record concerns Otsuka Pharmaceutical Co., Ltd., with an inspection on June 17, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · cd62a295-51a7-49ae-b140-a2c0ef894119
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1265342
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Otsuka Pharmaceutical Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 17, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Otsuka Pharmaceutical Co., Ltd.
- FDA Inspection 1107691 - 2019-10-22
- FDA Inspection 994655 - 2016-09-22
- FDA Inspection 887144 - 2014-06-17
- FDA Inspection 793343 - 2012-07-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.